Clearance evidence

Peptide

ATLPC0027686

Measured material

Specific molecular form

Endpoint

Clearance

ADMET domain

Excretion / Persistence

Value

Observation

Age has no effect on clearance of lanreotide based on population PK analysis in patients with GEP-NET which included 122 patients aged 65 to 85 years with neuroendocrine tumors.

Evidence role

Reported: reviewed reported observation that should not be pooled as a comparable value yet

Assay / model

human

Condition

Lanreotide · 6e4a41fd-a753-4362-87ee-8cc56ed3660d · 12.3 Pharmacokinetics · lanreotide age no clearance effect text · Age has no effect on clearance of lanreotide based on populat...

Scientific source

DailyMed

Open source

Clearance evidence

Developability

Resources

Measurement